把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| — |
| $9.15M |
| $23.24M |
| — |
| — |
| 73 |
| 尚无授权文本 |
| DLB Dolby Laboratories, Inc. | 2026-06-26 | 3/3 | $305M | $28.6M | $286.09M | 86.8% | 11.3% | 66 | 尚无授权文本 |
| PLAB PHOTRONICS INC | 2026-05-03 | 3/3 | $209.94M | $31.43M | $50.85M | 31.3% | 20.1% | 76 | 尚无授权文本 |
| GTLB Gitlab Inc. | 2026-04-30 | 3/3 | $264.16M | -$4.97M | $146.8M | 85.8% | -6.0% | 59 | 尚无授权文本 |
| PL Planet Labs PBC | 2026-04-30 | 3/3 | $94.15M | -$138.87M | -$1.87M | 53.5% | -37.1% | 77 | 尚无授权文本 |
| SLAB SILICON LABORATORIES INC. | 2026-04-04 | 3/3 | $213.5M | -$15.9M | -$4.9M | 59.5% | -8.0% | 84 | 尚无授权文本 |
| ABT ABBOTT LABORATORIES | 2026-03-31 | 3/3 | $11.16B | $1.08B | $916M | 56.2% | 12.0% | 80 | 尚无授权文本 |
| AIDX 20/20 Biolabs, Inc. | 2026-03-31 | 3/3 | $353,375 | -$2.17M | — | 17.8% | -408.4% | 8 | 尚无授权文本 |
| ALAB Astera Labs, Inc. | 2026-03-31 | 3/3 | $308.36M | $80.31M | $67.01M | 76.3% | 20.1% | 29 | 尚无授权文本 |
| BGLC BioNexus Gene Lab Corp | 2026-03-31 | 3/3 | $22,842 | -$543,575 | -$147,996 | -3.5% | -2366.2% | 70 | 尚无授权文本 |
| BIO BIO-RAD LABORATORIES, INC. | 2026-03-31 | 3/3 | $592.1M | -$527.1M | $78.1M | 52.3% | 5.8% | 80 | 尚无授权文本 |
| BIOA BioAge Labs, Inc. | 2026-03-31 | 3/3 | $2.77M | -$22.25M | -$24.07M | — | -915.4% | 22 | 尚无授权文本 |
| BLND Blend Labs, Inc. | 2026-03-31 | 3/3 | $30.84M | -$8.05M | — | 75.8% | -16.4% | 61 | 尚无授权文本 |
| ECL ECOLAB INC. | 2026-03-31 | 3/3 | $4.07B | $432.6M | $97.4M | 43.6% | 15.3% | 100 | 尚无授权文本 |
| ELAB PMGC Holdings Inc. | 2026-03-31 | 3/3 | $681,994 | -$4.97M | -$3.34M | 33.8% | — | 106 | 尚无授权文本 |
| ESTA ESTABLISHMENT LABS HOLDINGS INC. | 2026-03-31 | 3/3 | $59.88M | -$13.38M | -$6.16M | 70.7% | -10.9% | 102 | 尚无授权文本 |
| GROV Grove Collaborative Holdings, Inc. | 2026-03-31 | 3/3 | $36.22M | -$1.01M | -$977,000 | 54.8% | -2.5% | 85 | 尚无授权文本 |
| IDXX IDEXX LABORATORIES INC /DE | 2026-03-31 | 3/3 | $1.14B | $278.45M | $234.26M | 63.4% | 31.8% | 72 | 尚无授权文本 |
| LAB STANDARD BIOTOOLS INC. | 2026-03-31 | 3/3 | $21.15M | $127.07M | -$47.17M | 53.5% | -59.1% | 108 | 尚无授权文本 |
| LABT Lakewood-Amedex Biotherapeutics Inc. | 2026-03-31 | 3/3 | — | -$923,291 | — | — | — | 4 | 尚无授权文本 |
| LH LABCORP HOLDINGS INC. | 2026-03-31 | 3/3 | $3.54B | $277.8M | $70.5M | 28.7% | 10.8% | 159 | 尚无授权文本 |
| MLAB MESA LABORATORIES INC /CO/ | 2026-03-31 | 3/3 | $249.13M | $6.71M | $39.58M | 63.5% | 7.4% | 83 | 尚无授权文本 |
| MOBX MOBIX LABS, INC | 2026-03-31 | 3/3 | $970,000 | -$5.85M | — | 19.0% | -627.9% | 86 | 尚无授权文本 |
| QXL QUANTUM X LABS INC. | 2026-03-31 | 3/3 | — | -$605,000 | — | — | — | 64 | 尚无授权文本 |
| RKLB Rocket Lab Corp | 2026-03-31 | 3/3 | $200.35M | -$45.02M | -$77.4M | 38.2% | -27.9% | 107 | 仅元数据 |
| STTK Shattuck Labs, Inc. | 2026-03-31 | 3/3 | $0 | -$14.77M | — | — | — | 70 | 尚无授权文本 |
| VIVS VivoSim Labs, INC. | 2026-03-31 | 3/3 | $131,000 | -$13.84M | -$10.83M | 100.0% | -8768.7% | 72 | 尚无授权文本 |
| ZLAB Zai Lab Ltd | 2026-03-31 | 3/3 | $95.56M | -$51.02M | -$13.11M | 59.9% | -72.6% | 108 | 尚无授权文本 |
| CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2026-03-28 | 3/3 | $995.83M | -$14.84M | — | — | 12.0% | 84 | 尚无授权文本 |
| NA Nano Labs Ltd | 2025-12-31 | 3/3 | $3.84M | $19.27M | -$15.41M | -147.3% | 264.4% | 92 | 尚无授权文本 |
| RDY DR REDDYS LABORATORIES LTD | 2025-03-31 | 2/3 | — | $671M | — | — | — | 664 | 尚无授权文本 |
| VRAX Virax Biolabs Group Ltd | 2025-03-31 | 2/3 | — | -$6.07M | — | — | — | 74 | 尚无授权文本 |